Concord Drugs Ltd Q3 FY2024-2025 Results: Summary

Revenue
₹10.80Cr
Net Profits
₹0.23Cr
Net Profit Margins
2.13%
Highlights
Revenue:

Concord Drugs Ltd’s revenue fell -15.49% since last year same period to ₹10.80Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -12.69% fall in its revenue since last 3-months.

Net Profits:

Concord Drugs Ltd’s net profit jumped 195.83% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 475% jump in its net profits since last 3-months.

Net Profit Margins:

Concord Drugs Ltd’s net profit margin jumped 213.4% since last year same period to 2.13% in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 558.59% jump in its net profit margins since last 3-months.

FAQs

The revenue for Concord Drugs Ltd in the Q3 results 2024 was ₹10.80Cr.

The net profit for Concord Drugs Ltd in the Q3 results 2024 was ₹0.23Cr.

The net profit margin for Concord Drugs Ltd in the Q3 results 2024 was 2.13%.

The revenue for Concord Drugs Ltd in the Q3 results 2023 was ₹12.78Cr.

The net profit for Concord Drugs Ltd in the Q3 results 2023 was ₹0.24Cr.

The net profit margin for Concord Drugs Ltd in the Q3 results 2023 was -1.88%.